Related content

Current state of adjuvant therapy in resected pancreatic adenocarcinoma

By Bergenfeldt Magnus   Albertsson Maria  

Acta Oncologica, Vol. 45, Iss. 2, 2006-03 ,pp. : 124-135

Informa Healthcare

Access to resources Recommend Favorite

Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma

By Katz Matthew  

Annals of Surgical Oncology, Vol. 16, Iss. 4, 2009-04 ,pp. : 836-847

Springer Publishing Company

Access to resources Recommend Favorite

Clinical necessity of the immunohistochemical reassessment of paraaortic lymph nodes in resected pancreatic ductal adenocarcinoma

By            

Oncology Letters, Vol. 6, Iss. 5, 2013-01 ,pp. : 1189-1194

Spandidos Publications

Access to resources Recommend Favorite

Low Total Lymphocyte Count Is Associated with Poor Survival in Patients with Resected Pancreatic Adenocarcinoma Receiving a GM-CSF Secreting Pancreatic Tumor Vaccine

By Schueneman Aaron   Sugar Elizabeth   Uram Jennifer   Bigelow Elaine   Herman Joseph   Edil Barish   Jaffee Elizabeth   Zheng Lei   Laheru Daniel  

Annals of Surgical Oncology, Vol. 20, Iss. 3, 2013-12 ,pp. : 725-730

Springer Publishing Company

Access to resources Recommend Favorite

Intraoperative hyperthermia in conjunction with multi-schedule chemotherapy (pre-, intra- and post-operative), by-pass surgery, and post-operative radiotherapy for the management of unresectable pancreatic adenocarcinoma

By Kouloulias V. E.   Kouvaris J. R.   Nikita K. S.   Golematis B. C.   Uzunoglu N. K.   Mystakidou K.   Papavasiliou C.   Vlahos L.  

International Journal of Hyperthermia, Vol. 18, Iss. 3, 2002-05 ,pp. : 233-252

Informa Healthcare

Access to resources Recommend Favorite